Michele Geoffrion
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
A Rosella-PLIN2 knock-in mouse reveals lipophagy and immunometabolic interplay in atherosclerosis.
Journal: Autophagy
Published: May 21, 2026
Hyperlipidemia induces hippocampal inflammation and loss of vascularity and can be rescued by silencing RIPK1.
Journal: Scientific reports
Published: December 10, 2025
Age-Related Impairments in Immune Cell Efferocytosis and Autophagy Hinder Atherosclerosis Regression.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: February 13, 2025
Hematopoietic expression of cIAP2 drives inflammation and heart failure after myocardial infarction.
Hematopoietic expression of cIAP2 drives inflammation and heart failure after myocardial infarction.
Journal: Nature cardiovascular research
Published: January 05, 2024
Mitochondrial Fragmentation Promotes Inflammation Resolution Responses in Macrophages via Histone Lactylation.
Journal: Molecular and cellular biology
Published: October 09, 2023
Hyperlipidemia-induced hematopoiesis is repressed by MLKL in endothelial cells of the splenic niche.
Hyperlipidemia-induced hematopoiesis is repressed by MLKL in endothelial cells of the splenic niche.
Journal: Nature cardiovascular research
Published: November 23, 2022
ATF2 orchestrates macrophage differentiation and activation to promote antibacterial responses.
Journal: Journal of leukocyte biology
Published: October 15, 2022
miR-223 Exerts Translational Control of Proatherogenic Genes in Macrophages.
Journal: Circulation research
Published: May 25, 2022
Autophagy Is Differentially Regulated in Leukocyte and Nonleukocyte Foam Cells During Atherosclerosis.
Journal: Circulation research
Published: February 09, 2022
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy.
Journal: Nature communications
Published: November 11, 2021
RIPK1 Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in Mice.
Journal: Circulation
Published: November 23, 2020
Publisher Correction: RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in mice.
Journal: Nature metabolism
Published: October 09, 2020
Last Updated: 09/26/2026